Work

223eP The positive impact of a dedicated immunotherapy toxicity MDT in the early intervention and guidance of patients presenting with dermatological irAEs

Year: 2025

Type: article

Abstract: With increased use of immune checkpoint inhibitors (ICIs), incidences of immune-related adverse events (irAEs) are rising. Skin toxicities are the most common type, often presenting heterogeneously. While steroids remain the recommended treatment, establishment of an immunotherapy toxicity MDT for severe refractory irAEs may improve outcomes.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2025.101306

Authors: C. Fang, N. Shintre, A. Fusi, B. Ho, J. Chow, S.E. Germanou

Institutions: Imperial College London, St George's Hospital, St George’s University Hospitals NHS Foundation Trust, St George's, University of London

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,340